Follow
Zackary A. Cope
Title
Cited by
Cited by
Year
Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study
AL Oblak, PB Lin, KP Kotredes, RS Pandey, D Garceau, HM Williams, ...
Frontiers in aging neuroscience 13, 713726, 2021
1542021
Chemogenetic manipulations of ventral tegmental area dopamine neurons reveal multifaceted roles in cocaine abuse
SV Mahler, ZD Brodnik, BM Cox, WC Buchta, BS Bentzley, J Quintanilla, ...
Journal of Neuroscience 39 (3), 503-518, 2019
922019
Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder
JW Young, ZA Cope, B Romoli, E Schrurs, A Joosen, J van Enkhuizen, ...
Neuropsychopharmacology 43 (8), 1721-1731, 2018
592018
Premature responses in the five-choice serial reaction time task reflect rodents’ temporal strategies: evidence from no-light and pharmacological challenges
ZA Cope, AL Halberstadt, J van Enkhuizen, AD Flynn, M Breier, ...
Psychopharmacology 233, 3513-3525, 2016
552016
Modeling neurodevelopmental cognitive deficits in tasks with cross‐species translational validity
ZA Cope, SB Powell, JW Young
Genes, Brain and Behavior 15 (1), 27-44, 2016
432016
Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model
RW Brown, AM Maple, MK Perna, AB Sheppard, ZA Cope, RM Kostrzewa
Developmental neuroscience 34 (2-3), 140-151, 2012
422012
DREADD-mediated modulation of locus coeruleus inputs to mPFC improves strategy set-shifting
ZA Cope, EM Vazey, SB Floresco, GSA Jones
Neurobiology of learning and memory 161, 1-11, 2019
392019
Amphetamine increases activity but not exploration in humans and mice
A Minassian, JW Young, ZA Cope, BL Henry, MA Geyer, W Perry
Psychopharmacology 233, 225-233, 2016
362016
Chronic methamphetamine self-administration alters cognitive flexibility in male rats
BM Cox, ZA Cope, A Parsegian, SB Floresco, G Aston-Jones, RE See
Psychopharmacology 233, 2319-2327, 2016
352016
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species
ZA Cope, A Minassian, D Kreitner, DA MacQueen, M Milienne-Petiot, ...
Neuropharmacology 125, 254-262, 2017
272017
Oxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats
BZ Roberts, JW Young, YV He, ZA Cope, PD Shilling, D Feifel
Neuropharmacology 150, 15-26, 2019
262019
The five‐choice continuous performance task (5C‐CPT): a cross‐species relevant paradigm for assessment of vigilance and response inhibition in rodents
ZA Cope, JW Young
Current protocols in neuroscience 78 (1), 9.56. 1-9.56. 18, 2017
262017
Uncovering disease mechanisms in a novel mouse model expressing humanized APOEε4 and Trem2* R47H
KP Kotredes, A Oblak, RS Pandey, PBC Lin, D Garceau, H Williams, ...
Frontiers in Aging Neuroscience 13, 735524, 2021
252021
Dopamine transporter knockdown mice in the behavioral pattern monitor: a robust, reproducible model for mania-relevant behaviors
MA Kwiatkowski, G Hellemann, CA Sugar, ZA Cope, A Minassian, ...
Pharmacology Biochemistry and Behavior 178, 42-50, 2019
242019
Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood
ZA Cope, KN Huggins, AB Sheppard, DM Noel, DS Roane, RW Brown
Synapse 64 (4), 289-300, 2010
232010
Nicotine sensitization in adult male and female rats quinpirole-primed as neonates
MK Perna, ZA Cope, AM Maple, ID Longacre, JA Correll, RW Brown
Psychopharmacology 199, 67-75, 2008
182008
Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
B Sheppard, J Lehmann, ZA Cope, RW Brown
Behavioral neuroscience 123 (6), 1296, 2009
172009
Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study. Front Aging Neurosci 13: 713726
AL Oblak, PB Lin, KP Kotredes, RS Pandey, D Garceau, HM Williams, ...
112021
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
KD Onos, SK Quinney, DR Jones, AR Masters, R Pandey, KJ Keezer, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022
82022
Converging evidence that short-active photoperiod increases acetylcholine signaling in the hippocampus
ZA Cope, ML Lavadia, AJM Joosen, CJA van de Cappelle, JC Lara, ...
Cognitive, Affective, & Behavioral Neuroscience 20, 1173-1183, 2020
82020
The system can't perform the operation now. Try again later.
Articles 1–20